BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32352884)

  • 1. Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
    Lou E; Beg S; Bergsland E; Eng C; Khorana A; Kopetz S; Lubner S; Saltz L; Shankaran V; Zafar SY
    JCO Oncol Pract; 2020 Jul; 16(7):383-388. PubMed ID: 32352884
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
    Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
    JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
    [No Abstract]   [Full Text] [Related]  

  • 3. Palliative Care for Patients With Cancer in the COVID-19 Era.
    Mehta AK; Smith TJ
    JAMA Oncol; 2020 Oct; 6(10):1527-1528. PubMed ID: 32379855
    [No Abstract]   [Full Text] [Related]  

  • 4. Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.
    Liu R; Sundaresan T; Reed ME; Trosman JR; Weldon CB; Kolevska T
    JCO Oncol Pract; 2020 Jun; 16(6):289-293. PubMed ID: 32364826
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.
    Figuero-Pérez L; Olivares-Hernández A; Escala-Cornejo RA; Cruz-Hernández JJ
    JCO Oncol Pract; 2020 Jun; 16(6):348-349. PubMed ID: 32369410
    [No Abstract]   [Full Text] [Related]  

  • 6. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
    Nabhan C; Choueiri TK; Mato AR
    JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic.
    Dhawan N; Prommer E; Sinclair CT; Subbiah IM
    Curr Treat Options Oncol; 2020 Oct; 21(12):99. PubMed ID: 33119833
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
    Abid MB; Mughal M; Abid MA
    JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
    [No Abstract]   [Full Text] [Related]  

  • 9. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer.
    Rubinstein SM; Steinharter JA; Warner J; Rini BI; Peters S; Choueiri TK
    Cancer Cell; 2020 Jun; 37(6):738-741. PubMed ID: 32454025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and Coronavirus Disease 2019 (COVID-19)-Facing the "C Words".
    Shah UA
    JAMA Oncol; 2020 Sep; 6(9):1330-1331. PubMed ID: 32379856
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice.
    Marandino L; Necchi A; Aglietta M; Di Maio M
    JCO Oncol Pract; 2020 Jun; 16(6):295-298. PubMed ID: 32364846
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic.
    Moskowitz CS; Panageas KS
    JAMA Oncol; 2020 Sep; 6(9):1326-1327. PubMed ID: 32556067
    [No Abstract]   [Full Text] [Related]  

  • 13. Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.
    Balogun OD; Bea VJ; Phillips E
    JAMA Oncol; 2020 Oct; 6(10):1531-1532. PubMed ID: 32789508
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic.
    Jan I; Chen K; Sayan M; Uprety P; Laumbach RJ; Ennis RD; Haffty BG
    JAMA Oncol; 2020 Oct; 6(10):1632-1634. PubMed ID: 32852509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with cancer in the COVID-19 era: the clinical trial issue.
    Scarcia M; Ludovico GM; Fortunato A; Fiorentino A
    Tumori; 2020 Aug; 106(4):271-272. PubMed ID: 32508257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China.
    Wang Z; Wang J; He J
    JAMA Oncol; 2020 May; 6(5):631-632. PubMed ID: 32236504
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
    Mauri D; Kamposioras K; Tolia M; Alongi F; Tzachanis D;
    Lancet Oncol; 2020 Jun; 21(6):759-760. PubMed ID: 32410877
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy.
    Garrone O; Denaro N; Ruatta F; Vanella P; Granetto C; Vandone AM; Occelli M; Cauchi C; Ricci V; Fea E; Di Costanzo G; Colantonio I; Crosetto N; Merlano MC
    Tumori; 2020 Oct; 106(5):427-431. PubMed ID: 32703089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.
    Yu J; Ouyang W; Chua MLK; Xie C
    JAMA Oncol; 2020 Jul; 6(7):1108-1110. PubMed ID: 32211820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.
    Hofman P; Puchois P; Brest P; Lahlou H; Simeon-Dubach D
    Nat Med; 2020 Jun; 26(6):809-810. PubMed ID: 32382152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.